Effectiveness and tolerability of therapy with once-weekly exenatide versus basal insulin among injectable-naive patients with type 2 diabetes in a real-world setting in the United States - Loughlin, A M; Qiao, Q; Nunes, A P (Diabetes Spectrum, 2018)